Ketamine Therapy for Depression: What You Need to Know
A comprehensive guide to ketamine therapy for depression — how it works, who it helps, what treatment looks like, and how it differs from traditional antidepressants.
A Different Kind of Antidepressant
For decades, the standard approach to treating depression has been serotonin-based medications — SSRIs and SNRIs that take weeks to begin working and do not help everyone. Roughly one-third of people with depression do not respond adequately to these medications even after trying multiple options. This condition, known as treatment-resistant depression, has been one of psychiatry's most stubborn challenges.
Ketamine has changed that picture. Originally developed as an anesthetic in the 1960s, ketamine was found to produce rapid antidepressant effects — sometimes within hours — through an entirely different mechanism than traditional antidepressants. This discovery has been called one of the most significant advances in depression treatment in decades.
Psychedelic-assisted therapy encompasses several emerging treatments, and ketamine is currently the only one available through legal prescription in the United States.
How Ketamine Works for Depression
Traditional antidepressants primarily affect serotonin and norepinephrine systems. Ketamine works through the glutamate system — the brain's primary excitatory neurotransmitter — by blocking NMDA receptors and triggering a cascade of neurobiological effects.
The most important of these is a rapid increase in brain-derived neurotrophic factor (BDNF), a protein that supports the growth and connection of neurons. Depression is associated with reduced neural connectivity in key brain regions. Ketamine appears to rapidly restore these connections — essentially helping the depressed brain rewire itself.
This mechanism explains why ketamine can work so quickly. Traditional antidepressants slowly adjust neurotransmitter levels over weeks. Ketamine triggers immediate neuroplastic changes that can shift mood within hours.
Treatment Formats
Ketamine therapy is available in several forms:
IV Ketamine Infusions
The most studied format. A low dose of ketamine is administered intravenously over 40 minutes in a medical setting. A typical initial course involves six infusions over two to three weeks, followed by maintenance infusions as needed (often monthly or as symptoms return).
Esketamine (Spravato) Nasal Spray
The FDA-approved version, esketamine, is a nasal spray administered in a certified healthcare setting. After each dose, you are monitored for two hours before being released. The initial protocol typically involves twice-weekly doses for the first month, weekly for the second month, and then weekly or biweekly as maintenance.
Intramuscular (IM) Ketamine
A middle ground between IV and nasal spray — faster to administer than IV, with more predictable absorption than nasal spray. Offered by some clinics as an alternative.
Oral and Sublingual Ketamine
Some providers prescribe lozenges or tablets for at-home use, typically for maintenance between clinic visits. This format is less studied but growing in popularity due to convenience and lower cost.
What a Treatment Session Looks Like
Regardless of format, ketamine sessions share common elements:
- Screening — Medical and psychiatric evaluation to ensure safety. Uncontrolled hypertension, psychotic disorders, and certain other conditions are contraindications.
- Preparation — Discussion of what to expect and setting intentions for the session.
- Administration — The ketamine is given in a comfortable, calm environment. Sessions last 40 minutes to 2 hours depending on the route.
- The experience — Ketamine produces dissociative effects: altered perception, a sense of floating, changes in time perception, and sometimes vivid imagery. Most people describe the experience as dreamlike. A clinician monitors you throughout.
- Recovery — You remain at the clinic until effects have subsided. You will need someone to drive you home.
- Integration — Many psychedelic-assisted therapy programs include follow-up therapy sessions to process the experience and translate any insights into lasting change.
What the Evidence Shows
The research on ketamine for depression is substantial:
- Rapid onset: Multiple studies show significant improvement in depressive symptoms within 24 hours of a single infusion — compared to weeks for traditional antidepressants.
- Treatment-resistant depression: A meta-analysis found that roughly 50 to 70% of people with treatment-resistant depression respond to ketamine infusions.
- Suicidal ideation: Ketamine can rapidly reduce suicidal thoughts — one of its most clinically significant effects. Esketamine received an FDA indication specifically for depressive symptoms with acute suicidal ideation.
- Durability challenge: The main limitation is that effects are often temporary. A single infusion may produce relief lasting days to weeks. Ongoing maintenance treatment is typically needed to sustain benefits.
Who Is Ketamine Therapy For?
Ketamine therapy is primarily appropriate for:
- People with treatment-resistant depression who have not responded to two or more traditional antidepressants
- Those experiencing acute suicidal ideation who need rapid relief
- People looking for alternatives when standard medications cause intolerable side effects
It is generally not a first-line treatment for someone who has never tried standard antidepressants. The medical consensus is that traditional treatments should be explored first, with ketamine reserved for cases where they prove insufficient.
Costs and Access
Ketamine treatment is not inexpensive:
- IV infusions: $400 to $800 per infusion; six-infusion initial course runs $2,400 to $4,800
- Esketamine (Spravato): Often covered by insurance for treatment-resistant depression, though copays vary
- At-home oral ketamine: Some telehealth companies offer programs for $200 to $500 per month
- Insurance: Esketamine has the best insurance coverage. IV ketamine is often not covered. Coverage varies significantly by plan.
At the low doses used therapeutically and under medical supervision, the risk of addiction is low. Ketamine does have abuse potential at higher doses in recreational settings. Medical protocols use controlled dosing, supervised administration, and monitoring to minimize this risk. If you have a history of substance use disorder, discuss this with your provider.
A single ketamine infusion may provide relief lasting days to a few weeks. Most people require ongoing maintenance treatments to sustain benefits — often monthly infusions or regular esketamine doses. Combining ketamine with psychotherapy may help extend the duration of benefits.
Most medications can be continued, but certain interactions exist. MAO inhibitors and some other medications may need adjustment. Your provider will review your complete medication list before treatment. Never adjust medications without medical guidance.
Learn About Ketamine Therapy Options
Connect with a qualified provider to discuss whether ketamine treatment may be appropriate for your depression.
Take the Therapy Quiz